Letters
Journal’s withdrawal of article
Paper OK, title wrong
BMJ 2011; 342 doi: https://doi.org/10.1136/bmj.d2732 (Published 10 May 2011) Cite this as: BMJ 2011;342:d2732
- Nicholas Moore, professor and head1
- 1Department of Pharmacology, University of Bordeaux, 33076 Bordeaux, France
- nicholas.moore{at}pharmaco.u-bordeaux2.fr
The paper at the centre of the recent news article used disproportionality analysis to compare reports of pancreatitis and pancreatic or thyroid cancer to the US Food and Drug Administration associated with sitagliptine or exenatide versus four other drugs used in diabetes—rosiglitazone, nateglinide, repaglinide, and glipizide.1 2 They found …
Log in
Log in using your username and password
Log in through your institution
Subscribe from £173 *
Subscribe and get access to all BMJ articles, and much more.
* For online subscription
Access this article for 1 day for:
£38 / $45 / €42 (excludes VAT)
You can download a PDF version for your personal record.